Sumitomo Chemical Limite...

OTC: SOMMY · Real-Time Price · USD
13.52
0.02 (0.15%)
At close: Aug 15, 2025, 9:57 AM

Sumitomo Chemical Income Statement

Financials in JPY. Fiscal year is April - March.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021
Revenue
701.45B 663.44B 629.25B 612.14B 640.02B 619.99B 623.73B 563.14B 638.24B 728.48B 754.43B 774.13B 727.44B 712.67B 686.23B 638.98B
Cost of Revenue
513.75B 475.83B 450.91B 440.31B 553.45B 463.16B 496.57B 434.01B 505.66B 517.27B 523.09B 528.35B 525.91B 491.72B 444.95B 428.88B
Gross Profit
187.69B 187.6B 178.34B 171.84B 86.57B 156.84B 127.16B 129.13B 132.58B 211.21B 231.34B 245.79B 201.54B 220.94B 241.28B 210.1B
Operating Income
47.6B 24.18B 38.39B 11.5B -25.7B -26.95B -61.93B -71.75B -102.42B 10.87B -5.71B 66.28B 17.08B 53.65B 85.93B 58.34B
Interest Income
n/a n/a n/a 40.16B 38.46B 7.57B 18.03B 39.17B 15.9B 8.84B 29.84B 61.91B 32.67B 14.95B 8.72B 3.09B
Pretax Income
18.02B 70.61B -68.02B 37.48B -279.6B -56.16B -53.93B -49.86B -94.54B -32.01B 13.12B 113.66B 41.6B 62.76B 90.09B 56.69B
Net Income
10.01B 35.11B -30.91B 24.38B -202.06B -33.43B -43.19B -33.15B -53.32B -20.75B 11.07B 69.99B 28.47B 44.78B 53.23B 35.66B
Selling & General & Admin
154.72B 146.07B 149.06B 151.24B 67.71B 170.24B 171.14B 178.07B 13.37B 195.82B 251.28B 195.98B 40.22B 173.15B 168.18B 165.55B
Research & Development
n/a n/a n/a n/a 44.56B 44.1B n/a 45.5B 50.28B 47.5B n/a 46.3B 47.22B 40.9B 42.8B 41B
Other Expenses
-14.62B 17.35B -9.1B 9.1B n/a n/a 17.95B n/a n/a n/a -14.22B n/a n/a n/a n/a n/a
Operating Expenses
140.09B 163.42B 139.95B 160.34B 112.27B 170.42B 189.09B 188.84B 215.44B 183.23B 237.06B 192.18B 193.32B 173.37B 167.85B 166.5B
Interest Expense
n/a n/a n/a 14.18B 13.11B 36.77B 10.03B 17.29B 8.02B 51.72B 11B 14.53B 8.15B 5.84B 4.56B 4.74B
Selling & Marketing Expenses
n/a n/a n/a n/a -299.95B n/a n/a n/a 150.03B n/a n/a n/a 119.14B n/a n/a n/a
Cost & Expenses
653.85B 639.25B 590.86B 600.64B 665.73B 633.58B 685.66B 622.85B 721.1B 700.5B 760.14B 720.52B 719.23B 665.09B 612.8B 595.38B
Income Tax Expense
16.03B 9.63B -13.85B 3.6B -2.34B 1.74B 1.93B 1.32B -5.98B -642M 25.17B 28.55B 10.82B 14.9B 21.16B 17.81B
Shares Outstanding (Basic)
327.68M 327.21M 327.19M 327.29M 327.19M 327.07M 327.06M 327.04M 327.07M 326.99M 326.99M 326.99M 326.99M 65.4M 65.4M 65.4M
Shares Outstanding (Diluted)
327.69M 327.19M 327.19M 327.29M 327.19M 327.07M 327.06M 327.04M 327.07M 326.99M 326.99M 326.99M 326.99M 65.4M 65.4M 65.4M
EPS (Basic)
30.60 107.30 -94.45 74.50 -617.55 -102.2 -132.05 -101.35 -163.05 -63.45 33.85 214.05 87.05 684.75 813.75 545.25
EPS (Diluted)
30.55 107.30 -94.45 74.50 -617.55 -102.2 -132.05 -101.35 -163.05 -63.45 33.85 214.05 87.05 684.70 813.75 545.25
EBITDA
91.77B 77.09B 72.71B 62.42B -249.64B 19.39B -4.55B -20.41B -75.16B 69.28B 66.23B 97.32B 56.6B 86.9B 113.56B 81.17B
EBIT
59.6B 44.48B 39.46B 28.85B -289.73B -19.39B -43.91B -32.58B -86.52B 19.71B 24.12B 128.19B 49.75B 68.6B 94.65B 61.44B
Depreciation & Amortization
32.17B 32.62B 33.24B 33.57B 40.09B 38.78B 39.35B 39.3B 40.84B 41.3B 42.11B 43.71B 39.65B 39.32B 40.13B 37.57B